OBJECTIVE: To assess the efficacy of in-shoe orthoses that were designed based on shape and barefoot plantar pressure in reducing the incidence of submetatarsal head plantar ulcers in people with diabetes, peripheral neuropathy, and a history of similar prior ulceration. RESEARCH DESIGN AND METHODS: Single-blinded multicenter randomized controlled trial with subjects randomized to wear shape- and pressure-based orthoses (experimental, n = 66) or standard-of-care A5513 orthoses (control, n = 64). Patients were followed for 15 months, until a study end point (forefoot plantar ulcer or nonulcerative plantar forefoot lesion) or to study termination. Proportional hazards regression was used for analysis. RESULTS: There was a trend in the composite primary end point (both ulcers and nonulcerative lesions) across the full follow-up period (p = 0.13) in favor of the experimental orthoses. This trend was due to a marked difference in ulcer occurrence (p = 0.007) but no difference in the rate of nonulcerative lesions (p = 0.76). At 180 days, the ulcer prevention effect of the experimental orthoses was already significant (p = 0.003) when compared with control, and the benefit of the experimental orthoses with respect to the composite end point was also significant (p = 0.042). The hazard ratio was 3.4 (95% CI 1.3 to 8.7) for the occurrence of a submetatarsal head plantar ulcer in the control compared with experimental arm over the duration of the study. CONCLUSIONS: We conclude that shape- and barefoot plantar pressure-based orthoses were more effective in reducing submetatarsal head plantar ulcer recurrence than current standard-of-care orthoses, but they did not significantly reduce nonulcerative lesions.
Copyright American Diabetes Association. Reprinted with permission from The American Diabetes Association.

Full text (sometimes free) may be available at these link(s):      help

• PubMed Central
• DOI
• PubMed
• PDF locator
• publisher